Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression

被引:163
作者
Troyer, RM
Collins, KR
Abraha, A
Fraundorf, E
Moore, DM
Krizan, RW
Toossi, Z
Colebunders, RL
Jensen, MA
Mullins, JI
Vanham, G
Arts, EJ
机构
[1] Case Western Reserve Univ, Dept Med, Div Infect Dis, Cleveland, OH 44106 USA
[2] Case Western Reserve Univ, Mol Virol Program, Cleveland, OH 44106 USA
[3] Inst Trop Med, Immunol Lab, B-2000 Antwerp, Belgium
[4] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA
关键词
D O I
10.1128/JVI.79.14.9006-9018.2005
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
This study examined the relationship between ex vivo human immunodeficiency virus type 1 (HIV-1) fitness and viral genetic diversity during the course of HIV-1 disease. Primary HIV-1 isolates from 10 patients at different time points were competed against control HIV-1 strains in peripheral blood mononuclear cell (PBMC) cultures to determine relative fitness values. Patient HIV-1 isolates sequentially gained fitness during disease at a significant rate that directly correlated with viral load and HIV-1 env C2V3 diversity. A loss in both fitness and viral diversity was observed upon the initiation of antiretroviral therapy. A possible relationship between genotype and phenotype (virus replication efficiency) is supported by the parallel increases in ex vivo fitness and viral diversity during disease, of which the correlation is largely based on specific V3 sequences. Syncytium-inducing, CXCR4-tropic HIV-1 isolates did have higher relative fitness values than non-syncytium-inducing, CCR5-tropic HIV-1 isolates, as determined by dual virus competitions in PBMC, but increases in fitness during disease were not solely powered by a gradual switch in coreceptor usage. These data provide in vivo evidence that increasing HIV-1 replication efficiency may be related to a concomitant increase in HIV-1 diversity, which in turn may be a determining factor in disease progression.
引用
收藏
页码:9006 / 9018
页数:13
相关论文
共 76 条
[71]   Variable sensitivity of CCR5-tropic human immunodeficiency virus type 1 isolates to inhibition by RANTES analogs [J].
Torre, VS ;
Marozsan, AJ ;
Albright, JL ;
Collins, KR ;
Hartley, O ;
Offord, RE ;
Quiñones-Mateu, ME ;
Arts, EJ .
JOURNAL OF VIROLOGY, 2000, 74 (10) :4868-4876
[72]  
van't Wout AB, 1998, J VIROL, V72, P5099
[73]   A novel TaqMan real-time PCR assay to estimate ex vivo human immunodeficiency virus type 1 fitness in the era of multi-target (pol and env) antiretroviral therapy [J].
Weber, J ;
Rangel, HR ;
Chakraborty, B ;
Tadele, M ;
Martinez, MA ;
Martinez-Picado, J ;
Marotta, ML ;
Mirza, M ;
Ruiz, L ;
Clotet, B ;
Wrin, T ;
Petropoulos, CJ ;
Quiñones-Mateu, ME .
JOURNAL OF GENERAL VIROLOGY, 2003, 84 :2217-2228
[74]   VIRAL DYNAMICS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 INFECTION [J].
WEI, XP ;
GHOSH, SK ;
TAYLOR, ME ;
JOHNSON, VA ;
EMINI, EA ;
DEUTSCH, P ;
LIFSON, JD ;
BONHOEFFER, S ;
NOWAK, MA ;
HAHN, BH ;
SAAG, MS ;
SHAW, GM .
NATURE, 1995, 373 (6510) :117-122
[75]   Antibody neutralization and escape by HIV-1 [J].
Wei, XP ;
Decker, JM ;
Wang, SY ;
Hui, HX ;
Kappes, JC ;
Wu, XY ;
Salazar-Gonzalez, JF ;
Salazar, MG ;
Kilby, JM ;
Saag, MS ;
Komarova, NL ;
Nowak, MA ;
Hahn, BH ;
Kwong, PD ;
Shaw, GM .
NATURE, 2003, 422 (6929) :307-312
[76]   Drastic fitness loss in human immunodeficiency virus type 1 upon serial bottleneck events [J].
Yuste, E ;
Sánchez-Palomino, S ;
Casado, C ;
Domingo, E ;
López-Galíndez, C .
JOURNAL OF VIROLOGY, 1999, 73 (04) :2745-2751